IDEXX Laboratories, Inc. (BVMF:I1DX34)
Brazil
· Delayed Price · Currency is BRL 777.26
-9.08 (-1.15%)
At close: Dec 3, 2025
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $1.11B USD in the quarter ending September 30, 2025, with 13.29% growth. This brings the company's revenue in the last twelve months to $4.17B, up 8.39% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm)
$4.17B
Revenue Growth
+8.39%
P/S Ratio
13.90
Revenue / Employee
$378.86K
Employees
11,000
Market Cap
308.64B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Hypera | 6.97B |
| Fleury | 8.07B |
| Odontoprev | 2.53B |
| Diagnósticos da América | 12.57B |
| Empreendimentos Pague Menos | 14.27B |
| Blau Farmacêutica | 1.77B |